3629 results for «754»

Filter By

3629 results

Hot TAVI topics - Emerging indications

27 Nov 2022 – From PCR London Valves 2022

Consult this session on hot TAVI topics to learn more about the under-treatment problem of patients with aortic valve disease, the rationale behind emerging TAVI indications and ongoing trials, as well as the nuances of patient selection and the key role of cardiac imaging in identifying markers of...

Hot TAVI topics - Emerging indications

Primary mitral regurgitation: treatment options when the anatomy is complex

27 Nov 2022 – From PCR London Valves 2022

Take a look at these presentations to learn more about complex primary mitral regurgitation (and how to differentiate it from simple disease), to understand why it is complex and to know what the treatment options are.

Primary mitral regurgitation: treatment options when the anatomy is complex

Repair vs. replacement for the treatment of tricuspid valve disease

27 Nov 2022 – From PCR London Valves 2022

Watch this session on tricuspid valve disease to learn more about its current modes of treatment (including new and emerging devices), to understand which patients are the best candidates for this procedure and to explore the challenges that may be encountered during it.

Repair vs. replacement for the treatment of tricuspid valve disease

TAVI: emerging evidence

27 Nov 2022 – From PCR London Valves 2022

Through the 5 abstracts of this PCR LV 2022 session, follow the comparison between last-generation balloon and self-expandable TAVR for bicuspid aortic valve stenosis, and the comparison between multiple tools to assess the risk of mortality after TAVR, evaluate the impact of post-TAVI vascular complications, and...

TAVI: emerging evidence

TAVI challenges: session 1

27 Nov 2022 – From PCR London Valves 2022

Discover a series of TAVI challenges shared by your peers: a transfemoral TAVR through a severely tortuous and horizontal aorta in a morbidly obese patient, TAVI for pure non-calcified severe aortic regurgitation in a large annulus, peripheral access calcifications and more.

TAVI challenges: session 1

TMVR challenges

27 Nov 2022 – From PCR London Valves 2022

Challenges in this session of PCR LV 2022 include hybrid valve implantation for mitral annular calcification, transcatheter double-valve implantation complicated by mitral bioprosthesis migration, and transcatheter transseptal mitral valve implantation. Watch now to find out more!

TMVR challenges

TRISCEND, ACURATE neo2, the LuX-Valve System: Top Late-Breaking Trials from PCR London Vaves 2022

27 Nov 2022 – From PCR London Valves 2022

Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions and learn more about the latest evidence evidence concerning new transcatheter valve devices, emerging innovative devices as well as highlighted content from the EuroIntervention journal.

Top Late-Breaking Trials

TAVI: Late-Breaking Trials and Innovations

27 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions, and learn more about the early safety and performance of the Vienna TAVI system, the new-generation transcatheter aortic valve platforms performance in native pure aortic regurgitation, and more!

TAVI: Late-Breaking Trials and Innovations

CLASP II TR, TriBAND, bRIGHT: Late-Breaking Trials on tricuspid intervention

27 Nov 2022 – From PCR London Valves 2022

Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions in this session: the CLASP II TR on transcatheter tricuspid valve repair, the TriBAND study one-year outcomes on transcatheter tricuspid annular reduction, and the bRIGHT trial on real-world outcomes for TEER.

Tricuspid - Late-Breaking Trials

Rapid-fire abstracts: session 4

27 Nov 2022 – From PCR London Valves 2022

In this PCR LV 2022 session dedicated to TAVI, take advantage of the 7 abstracts to learn more about the impact of TAVI for pure regurgitation on the severity of concomitant mitral regurgitation, the deformation of transcatheter heart valve and haemodynamics after aortic ViV, and much...

Rapid-fire abstracts: session 4

Rapid-fire abstracts: session 3

27 Nov 2022 – From PCR London Valves 2022

Everything you need to know about the OPERA-TAVI registry, the UK TAVI registry, the TAVI-COMIC study, or the external validation of the TRI-SCORE in patients undergoing isolated tricuspid valve surgery, among others, can be found in this session of PCR LV 2022.

Rapid-fire abstracts: session 3

Mitral valve in mitral annular calcification (MAC) - Recorded case

27 Nov 2022 – From PCR London Valves 2022

A 53-year-old male with a history of SAVR (Perimount 23) 10 years ago and chest radiotherapy (lymphoma) presents a severe mitral stenosis (MAC) with preserved LV function and impaired RV function.
On sentinel cerebral protection, the operators perform a transseptal puncture with electrifying a non-stiff guide wire,...

Recorded case: Mitral valve in MAC

Transcatheter mitral valve replacement

18 May 2022 – From EuroPCR 2022

In this session focusing on transcatheter mitral valve replacement, learn more about: who are the optimal patients, two clinical case examples - "meet the patient" and "a live CT analysis", and what to analyse and measure during the CT analysis.

Transcatheter mitral valve replacement

AICT-AsiaPCR 2022 Opening Ceremony

06 Oct 2022 – From AICT-AsiaPCR 2022

After two years without being able to meet, the joy of opening this 2022 session of the AICT-AsiaPCR Congress is palpable in this video broadcasting the opening ceremony. After a quick retrospective of the previous editions, the presenters unveil the objectives of this 2022 version and...

AICT-AsiaPCR 2022 Opening Ceremony

Beyond the guidelines of STEMI management: challenges in Southeast Asia

06 Oct 2022 – From AICT-AsiaPCR 2022

In this session, observe several challenging STEMI cases, such as a 48-year-old non-smoking Thai man with gout admitted for chest pain, or a 68-year-old woman with a history of HT, DM2, and PAD who presented with an anterior lateral STEMI and was indicated for PPCI, and...

Beyond the guidelines of STEMI management: challenges in Southeast Asia

PCI calcified lesion - Session with LIVE case

06 Oct 2022 – From AICT-AsiaPCR 2022

Watch this LIVE case preceded by a discussion regarding the PCI of a calcified lesion on a 75-year-old male with hypertension and hyperlipidemia who presented with Class III angina. Non-invasive evaluation showed significant LAD and RCA disease, normal LVEF and no significant valvular disease...

PCI calcified lesion

Ultra-low contrast PCI - Session with LIVE case

06 Oct 2022 – From AICT-AsiaPCR 2022

Watch this LIVE case followed by a discussion regarding a 75-year-old female with hypertension, hyperlipidemia, diabetes and stage 3 CKD, presenting with class III angina. The lab investigations revealed a diffuse triple vessel disease...

Ultra-low contrast PCI

Strategies for successful medical writing

06 Oct 2022 – From AICT-AsiaPCR 2022

What a pleasure to be able to read and re-read one of your own articles once it has been published! Follow this session to get tips and tricks on how to get published and produce quality writing, and to learn how to use all media, including...

Strategies for successful medical writing

Lifetime management of patients with aortic stenosis

06 Oct 2022 – From AICT-AsiaPCR 2022

In this AICT-AsiaPCR 2022 session, review a ViV case to consider coronary occlusion and CT analysis, and examine a TAVI case to discuss failed TAVI bioprosthesis, so as to develop strategies for patients with AS and long-life expectancy.

Lifetime management of patients with aortic stenosis

Duration of DAPT in high bleeding risk and FFR guided PCI vs. CABG for TVD: a guide to interpreting non-inferiority trials

07 Oct 2022 – From AICT-AsiaPCR 2022

Take advantage of this AICT-AsiaPCR 2022 session to learn in detail about the FAME 3 and MASTER-DAPT trials and how to use their results in daily practice, and to better understand what is behind the term "non-inferiority" and when and how to choose a non-inferiority margin.

Duration of DAPT in high bleeding risk and FFR guided PCI vs. CABG for TVD: a guide to interpreting non-inferiority trials
Didn’t find what you were looking for?